glp 1 agonist eye side effects A potentially blinding condition is a very rare effect of the GLP-1 receptor semaglutide (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded. https://www.medpagetoday.com/ophthalmology/generalophthalmology/115938?trw=no GLP-1 Drugs and Ocular Disease:
Description
doi: 10.1177/1479164111404257 Erratum in: Diab Vasc Dis Res
Retatrutide is not approved for human use
Jorsal A, Kistorp C, Holmager P, et al
Although GLP-1RAs can play a favorable role in improving heart failure based on pre-clinical studies, whereas some clinical evidence relevantly have reported that GLP-1RAs treatment could be associated with adverse heart failure events, eg
[DOI] [PubMed] [Google Scholar] 392.Pyke C., Heller R.S., Kirk R.K., Orskov C., Reedtz-Runge S., Kaastrup P
